Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD3974 After Single and Multiple Ascending Dosing to Healthy Participants

NCT07290283 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07290283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07290283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD3974 After Single and Multiple Ascending Dosing to Healthy Participants
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Recruiting
Start date
December 10, 2025
Completion date
December 8, 2026
Enrollment
176 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants